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ABSTRACT 
The osseointegration process of dental implants begins with osteoblast differentiation and proliferation, which is an 
important aspect of the bone regeneration process. Platelet-rich fibrin (PRF) is a platelet that contains a large amount of 
fibrin and growth factor, which is widely used to accelerate bone regeneration. This study aims to determine the effect 
of PRF on the acceleration of osteoblast proliferation after endosseous dental implant insertion. Twelve male Wistar 
rats weighing 250 to 300 gr of 8 to 15 weeks as an animal model were divided into two groups, the control group and 
treatment group, based on days and PRF treatment. Three ml of Wistar rat blood was obtained and centrifuged for 12 
minutes at a speed of 2700 rpm to make PRF. Afterward, platelet-rich fibrin was applied to implant bed, and the dental 
implant was inserted at the lateral epicondyle of the right femur in 3 mm depth and 1.8 mm diameter dimension. In 
control groups, dental implants were immediately inserted after implant bed preparation without PRF administration. 
Observation of the Wistar rats was carried out on days 14 and 28 for each group. The rats were terminated according 
to the timeline of group design. The epicondylus lateralis femoris dextra bone of the rats was taken and fixed with 10% 
buffered formalin solution. Then, histological samples were made with hematoxylin-eosin staining. Sample observation 
was done under a light microscope to calculate the number of osteoblasts. The data were analyzed using the two-way 
ANOVA test, followed by LSD post hoc test. Based on the two-way ANOVA test, there was a significant difference 
between control groups and treatment groups (p<0.05), and there were significant differences between the observation 
result of days 14 and 28 (p<0.05). The application of PRF increased osteoblast proliferation for the first 14 days, but the 
rate decreased after that. Based on the LSD post hoc test, there were differences in osteoblast proliferation between 
the treatment and control group (p<0.05). Thus, it is concluded that platelet-rich fibrin increased the acceleration of 
osteoblast proliferation after endosseous dental implant insertion.
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INTRODUCTION
A dental implant is normally used to replace 
missing teeth and ideally to restore mastication, 
esthetic, phonetic function, and tooth-supporting 
tissue. A dental implant is placed by way of 
surgery into the jawbone as a replacement of 
roots to support prosthesis and dental bridges.1 
The material of a dental implant is an important 
factor for osseointegration. Some materials, such 
as stainless steel, tantalum, and ceramic produce 
osseointegration, are widely used today. Titanium, 
however, remains the first choice of dental 
implant material because it is a reactive metal 
that spontaneously creates an oxide layer when 
exposed to air. This layer is waterproof and can 
hold against body fluid, can be formed into small 
parts, and thus can be implanted into the alveolar 
bone. In addition, this material is known to withstand 
the force of mastication to enable the bone growth 
around the surface of titanium.2
Osseointegration, as the main phenomenon in 
dental implants, is a form of attachment between 
bone tissues and dental implant surfaces embedded 
in the alveolar bone. Biomolecular events and 
bone cells play important roles in supporting 
osseointegration. During insertion of a dental 




implant, bone-to-implant contact (BIC) is the main 
objective because this condition showed perfect 
osseointegration process, which resulted in a bond 
between substructure and surrounding alveolar 
bone without interference from fibrous tissues.3
Bone healing stages reflect the 
osseointegration stages. The osseointegration 
process begins from the insertion of a dental 
implant, bleeding, and acute inflammatory response 
during bone drilling, which is followed by a blood 
clot between implant and bone. Afterward, procallus 
is formed, and simultaneously, mesenchymal cells 
are differentiated into osteoblasts and fibroblasts. 
Osteoblasts then produce calcified fiber. 
Fibrocartilage, which is resulted from procallus, is 
developed into a woven bone in the third and fourth 
weeks. After seven weeks of post-implant insertion, 
the woven bone becomes lamellar bone. It is a more 
mineralized bone; therefore, it stabilizes the implant. 
Radiographically, the bones surrounding the dental 
implant in this stage are normal. The final stage of 
osseointegration can be seen from the maturation 
of bone surrounding the implant, increased density, 
and hardness. This stage continues until 1-year 
post-implant insertion.4
The surface of an implant plays an important 
role in the first stage of BIC. The formation of the 
bone surrounding the implant depends on bone 
healing ability. Thus, a chemically modified implant 
surface, such as a combination of organic substances 
to the titanium layer, has successfully increased the 
BIC level. Implant abutment is usually place after 
insertion at about 3-6 months for the mandible and 
6-9 months for maxilla. It is necessary to consider 
the application of preparations that trigger bone 
regeneration and extend the osseointegration. 
There have been various methods to reduce the 
amount of time needed to reach osseointegration.5 
Growth factors (GFs) are among the factors 
that induce osseointegration, and thus creating 
replication and differentiation of osteoprogenitors 
and tissue maturation. Osteoprogenitors are 
primitive mesenchymal cells that produce 
osteoblasts during bone growth and osteocytes 
in the layers inside bone tissues.6 In hematology, 
PRF is one of the growth factors available in human 
blood. PRF has been used widely for alveolar bone 
regeneration, sinus lifting procedure, and gingival 
recession closure in the form of membrane.7 PRF 
is known to induce mitotic activity in osteoblasts, 
gingival fibroblasts, periodontal ligament cells, and 
suppress epithelial proliferation. PRF membrane 
inhibits early invagination of gingival epithelium, and 
thus it can act as a barrier for epithelial migration.8
During blood sample examination, PRF gives 
a lot of important elements of its use, a rich number 
of platelets, and cytokine leukocytes. Platelets 
in PRF contain a lot of growth factors, including 
platelet-derived growth factor (PDGF), transforming 
growth factor-beta (TGF-β), insulin growth factor 
(IGF), endothelial growth factor (EGF), fibroblast 
growth factor (FGF), and bone morphogenetic 
protein (BMP). These growth factors hold important 
roles in hemostasis, angiogenesis, proliferation, 
and differentiation of osteoblasts.9 This study aims 
to determine the effect of PRF to the acceleration 
of osteoblasts proliferation post endosseous dental 
implant insertion (in vivo study).
MATERIALS AND METHODS
This study is a laboratory experiment (in vivo) on 12 
male Wistar rats of 8-15 weeks old with the average 
weight of 250-300 grams. The ethical approval of 
this study was obtained from ethical committee of 
Gajah Mada University, Faculty of Dentistry No. 
001534/KKEP/FKG-UGM/EC/2018. Wistar rats 
were divided into treatment and control groups 
(n = 6) with 14 and 28-observation days for each 
group. This study used the endosseous implant 
(SD implant, C-TECH) of 1.8 mm diameter that was 
cut evenly at 3 mm. The PRF used in this study was 
obtained from the blood of animal models that were 
centrifuged for 12 minutes at 2700 rpm speed using 
centrifugation machine (MPW-55, MPW med).
The right upper legs of Wistar rats were 
anesthetized intramuscularly using 1:1 xylazine 
and ketamine (each was 0.15 ml). In the treatment 
group, 2 ml of blood was extracted from orbital 
sinus for PRF, and it was centrifuged for 12 minutes 
at 2700 rpm. The PRF membrane was taken from 
the second layer of centrifugation result. Full-
thickness flap incision of ± 1 cm was performed on 
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the femoral bone of Wistar rats that were given PRF 
in the drilling socket and implant insertion without 
PRF are presented in Table 1.
The data resulted in ratio scale and the scale 
was analyzed using two-way ANOVA parametric 
test. The two-way ANOVA test requires normally 
distributed data and homogenous variance. The 
normality test using Shapiro-Wilk showed p>0.05. 
It means that the data were normally distributed. 
The homogeneity test using Levene’s test 
showed p 0.852 (p>0.05), therefore the data were 
homogenous. According to both tests, the data 
were eligible for parametric test. The result of two-
way ANOVA parametric testis presented in Table 2.
The results of two-way ANOVA (Table 2) 
indicate that there was a significant difference of 
osteoblasts proliferation between the PRF group 
and control group (p<0.05). Afterward, the LSD 
Post Hoc test was used to determine the group with 
significant differences. The Post Hoc test revealed 
that there was significant difference of osteoblasts 
proliferation between all treatment groups and 
observation days (p<0.05). The results of LSD Post 
Hoc test can be seen in Table 3.
Table 1. Means and standard deviation of osteoblasts 
proliferation with and without platelet-rich fibrin (PRF) on day 
14 and 28
Group Control PRF
Day 14 52.33 ± 5.82 142.06 ± 8.69
Day 28 65.95 ± 5.74 184.22 ± 7.56
Table 2. The results of two-way ANOVA of osteoblasts 
proliferation
Variable F  p value
PRF 1300.72 0.000*
Day 93.53 0.000*
Group * day 24.51 0.000*











K day 14 -
K day 28 0.003* -
P day 14 0.000* 0.000* -
P day 28 0.000* 0.000* 0.000* -
the right femoral lateral epicondyle. Bone drilling on 
the incised area was done using a pilot drill with 
1.3 mm diameter and 2 mm depth, and 500 rpm 
bur speed was performed to form implant bed. 
Treatment group was given 0.1 ml of PRF into 
the implant socket, and the implant was placed 
into the socket at bone level. Meanwhile, in the 
control group, the implant was immediately placed 
after implant bed preparation. The incision wound 
was sutured to close the implant. Wistar rats were 
maintained according to the designed observation 
days, of 14 and 28 days. Afterward, the Wistar rats 
were terminated according to treatment group using 
dislocation method. The bone in the implant area 
was taken, and bone tissues were fixated using 
10% buffered formalin and left for at least 24 hours. 
Bone tissues were cleaned from soft tissues along 
the surface of the bone. The bone was immersed 
in formic acid-HCL solution for 48 hours to soften 
the tissue. The implant was taken out carefully to 
avoid damage to the bone thread. Subsequently, 
the tissues were embedded in wax blocks, and 
cut using microtome to form preparations. The 
preparations were stained using hematoxylin-eosin 
then observed using a light microscope. 10x, 40x, 
and 100x magnifications were needed to observe 
the preparations. Magnification 10x was used to 
observe implant socket, 40x to observe implant 
thread, and 100x to observe osteoblasts on the 
sides of the thread. Implant socket was divided into 
two, i.e. right and left thread sides, then observation 
and osteoblasts count were performed manually at 
100x magnification. All osteoblasts in one thread 
were counted using a tally counter, and the count 
was repeated for 3 times and averaged.
The experiment resulted in ratio scale data, 
and thus parametric test was used. The data were 
tested using one-way ANOVA using significance 
level of 95%. If the ANOVA test showed differences, 
the Post Hoc Least Significant Difference (LSD) 
test was performed to determine which group had 
significant differences.
RESULTS
The results of means and standard deviation of 
osteoblasts proliferation post-implant insertion in 





This in vivo study aims to determine the effect of 
PRF to the acceleration of osteoblasts proliferation 
post endosseous dental implant insertion. The 
analysis of variance revealed the significance level 
of p<0.05. Therefore, the hypothesis of this study is 
accepted. In addition, it is known that the application 
of PRF can increase the acceleration of osteoblasts 
proliferation post endosseous dental implant 
insertion, and thus accelerating osseointegration. 
There were significant differences between control 
group and PRF group. The PRF application showed 
good results on osteoblasts proliferation because 
the growth factor (GF) in PRF triggered osteoblast 
growth. GFs that played an important role were 
PDGF, FGF, vascular endothelial growth factor 
(VEGF), and TGF-β1. PDGF contained in PRF 
helped stimulate osteoblast proliferation to develop 
new cells. FGF in PRF accelerated osteoblast 
maturation, thus fastening the proliferation of new 
osteoblasts formed. TGF-β1 is a protein-rich GF 
that has an important role in bone regeneration, 
epithelial cell growth, and osteoblast proliferation 
control. TGF-β1 is also a strong agent in inhibiting 
the development of osteoclasts and bone 
resorption. Interleukin-β 1 (IL-β1) in GF is one of the 
main keys of the differentiation and proliferation of 
osteoblasts. IL-6 GF is also a multifunction cytokine 
that activates and triggers osteoblasts proliferation.6 
There was an interaction between observation 
times, i.e. between days 14 and days 28 of the 
PRF application to osteoblasts proliferation post 
endosseous implant insertion. Proliferation and 
differentiation of osteoblasts were derived from 
mesenchymal stem cells (MSC), which were 
controlled by BMP. In BMP, there was TGF-β1, which 
played a role in osteoblasts proliferation. The PRF 
application in an implant socket, which contained 
a lot of growth factors, accelerated osteoblasts 
proliferation because TGF-β1 was constituted in 
GF. This proliferation acceleration occurred as long 
as the active period of PRF in the socket. Therefore, 
after 14 days post-implant insertion, the PRF had 
started to resorb, and thus allowing the normal 
occurrence of osteoblasts proliferation.
The number of osteoblasts in PRF group 
on days 28 showed less acceleration than that 
of the first 14 days. This was not due to the fact 
that osteoblasts no longer formed, but was more 
attributed to the fact that osteoblasts had started to 
differentiate into osteocytes. Based on the process 
of bone formation, fibrocartilage started to form in 
the fourth week as the result of osteoblast and fiber 
in the osteointegration process.10
The LSD post hoc test showed significant 
differences in each group. The numbers of 
osteoblasts were higher in days 14 of PRF group 
compared to those of days 14 of control group. 
This showed the effectivity of PRF application in 
the socket for implant insertion. The number of 
osteoblasts in days 14 of PRF group was almost 
three times of the number of osteoblasts in days 14 
of control group. The number of osteoblasts in days 
28 of PRF group was less than that of the first 14 
days. This result showed the effectiveness of PRF 
to increase in the first 14 days despite the gradual 
decrease after the remaining 14 days. This may 
be due to the fact that PRF acted as the GF-rich 
fibrin network, and thus allowing the gradual and 
controlled GF release.11
CONCLUSION
The application of PRF can accelerate osteoblasts 
proliferation post endosseous dental implant 
insertion. 
SUGGESTION
To develop this topic, further studies need to use a 
specially designed dental implant for animals.
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